Key Takeaways
- • Auxxo closed its second Female Catalyst Fund at €33.3 million (USD$38.2 million), a 75% increase from the first vintage's €19 million close in 2021, targeting pre-seed and seed-stage female co-founded startups across Europe.
- • The fund's investment criteria require at least one female founder holding a minimum of 20% of founder shares; the current portfolio comprises 11 companies spanning climate data, AI, robotics, space tech, deep tech, and healthcare sectors.
- • Limited partners include institutional anchors (Aurum Impact, EnBW New Ventures, Cherry Ventures, Speedinvest, and European Investment Fund) alongside family offices and business angels, with over 50% of LPs being women.
- • Auxxo simultaneously launched a pan-European Founder Matchmaking Platform designed to address female founder underrepresentation—women comprise only 19% of founders in Germany, signaling a structural gap in the European startup ecosystem.
- • The fund's 11 portfolio companies include Emidat, Resolutiion, Stanhope AI, Kito AI, Marble Imaging, Noxon GmbH, SEAL Robotics, BioOrbit, NanoStruct GmbH, Delta Labs, and Radiogenesis.
Summary
Berlin-based venture capital firm Auxxo announced the final close of Auxxo Female Catalyst Fund II on September 1, 2026, at €33.3 million (USD$38.2 million). The fund represents a significant expansion of Auxxo's debut female-focused vehicle, which closed at €19 million in 2021, marking a 75% increase in capital deployed toward gender-diverse founding teams in early-stage European startups.
Auxxo, founded in 2019, operates with a sector-agnostic mandate focused exclusively on pre-seed and seed-stage startups with at least one female co-founder holding a minimum of 20% of founder equity. The firm's thesis directly addresses structural underrepresentation of women in venture capital: according to the company's analysis, women represent only 19% of founders in Germany, highlighting a persistent market inefficiency that Auxxo aims to exploit through disciplined investment in overlooked talent pools.
The Fund II portfolio currently comprises 11 companies spanning climate technology, artificial intelligence, robotics, space, deep tech, and healthcare sectors: Emidat, Resolutiion, Stanhope AI, Kito AI, Marble Imaging, Noxon GmbH, SEAL Robotics, BioOrbit, NanoStruct GmbH, Delta Labs, and Radiogenesis. This diversification across high-growth verticals positions the fund to capture upside across multiple emerging technology markets.
The limited partner base reflects sophisticated institutional participation, including Aurum Impact, EnBW New Ventures, Cherry Ventures, Speedinvest, and the European Investment Fund serving as anchor investor, alongside European family offices and business angels. Notably, over 50% of LPs are women, aligning incentive structures with the fund's gender-diversity mandate and potentially improving information flow and founder network access.
Concurrent with the final close, Auxxo launched a pan-European Founder Matchmaking Platform intended to reduce friction in early-stage team formation, directly targeting the founder supply-side constraint limiting female entrepreneurship. This infrastructure play complements the capital deployment strategy and may create additional value through improved matching efficiency across Auxxo's pipeline.
Auxxo, founded in 2019, operates with a sector-agnostic mandate focused exclusively on pre-seed and seed-stage startups with at least one female co-founder holding a minimum of 20% of founder equity. The firm's thesis directly addresses structural underrepresentation of women in venture capital: according to the company's analysis, women represent only 19% of founders in Germany, highlighting a persistent market inefficiency that Auxxo aims to exploit through disciplined investment in overlooked talent pools.
The Fund II portfolio currently comprises 11 companies spanning climate technology, artificial intelligence, robotics, space, deep tech, and healthcare sectors: Emidat, Resolutiion, Stanhope AI, Kito AI, Marble Imaging, Noxon GmbH, SEAL Robotics, BioOrbit, NanoStruct GmbH, Delta Labs, and Radiogenesis. This diversification across high-growth verticals positions the fund to capture upside across multiple emerging technology markets.
The limited partner base reflects sophisticated institutional participation, including Aurum Impact, EnBW New Ventures, Cherry Ventures, Speedinvest, and the European Investment Fund serving as anchor investor, alongside European family offices and business angels. Notably, over 50% of LPs are women, aligning incentive structures with the fund's gender-diversity mandate and potentially improving information flow and founder network access.
Concurrent with the final close, Auxxo launched a pan-European Founder Matchmaking Platform intended to reduce friction in early-stage team formation, directly targeting the founder supply-side constraint limiting female entrepreneurship. This infrastructure play complements the capital deployment strategy and may create additional value through improved matching efficiency across Auxxo's pipeline.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.